🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementJoint pain improvement vs new joint pain — a paradox on GLP-1 Page 2

Joint pain improvement vs new joint pain — a paradox on GLP-1

Dr.RheumBOS Fri, May 1, 2026 at 12:22 AM 28 replies 752 viewsPage 2 of 6
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
May 1, 2026 at 5:41 AM#6
RetaRick_CA said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

Last edited: May 1, 2026 at 7:41 AM
9 4fiona_VT, denise_HTX, raj_cambridge and 6 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
May 1, 2026 at 7:46 AM#7

The figures, for anyone assembling their own picture. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

8 3JenPlateau, SallyK_inj, CryptoCarl and 5 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
May 1, 2026 at 9:51 AM#8
DanielChem_CHI said:
I dislike how confidently this board tells people to push through.

There is a second half to this that has not been said yet. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: May 1, 2026 at 2:51 PM
7 2jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
sophie_paris
Member
212
890
Nov 2024
Paris, FR
May 1, 2026 at 11:56 AM#9

A narrower follow-up, since the general answer is now clear:

Whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out?

6 1AussieAnna, BethLabQueen, ChrisMacros and 3 others
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
May 1, 2026 at 9:55 PM#10

OP back with an update, since a thread like this is useless without one.

Update. It was not the dose, it was that I had stopped drinking anything because drinking made me feel full. Fixing that fixed most of it.

20 18Dr.PulmRoch, maya_sedona, stefan_berlin and 17 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register